Public tender
Delivery of a medicinal product containing the active substance belantamab mafodotin, covered by reimbursement under drug program B.54, for the treatment of patients with multiple myeloma.
UNIWERSYTECKI SZPITAL KLINICZNY NR 1
Details
- Submission deadline
- 29. Juni 2026
- Country
- Estimated value
- On request
- Source
- View on the procurement portal
Documents
- Leistungsverzeichnis
- Preisblatt
- Bewerbungsbedingungen
- Vertragsbedingungen
- Anlagen und Pläne
Get started
Book a demo.
See what BOND finds for your company — tenders, suppliers, and partners you'd never discover on your own. Cancel any month, anytime.